Education
About Us
Working with TipRanks
Follow Us
Raily Aesthetic Medicine International Holdings Limited (HK:2135)
:2135
Total Valuation
Raily Aesthetic Medicine International Holdings Limited has a market cap or net worth of HK$70.19M. The enterprise value is HK$1.23B.
Market CapHK$70.19M
Enterprise ValueHK$1.23B
Share Statistics
Raily Aesthetic Medicine International Holdings Limited has 557,077,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding557,077,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Raily Aesthetic Medicine International Holdings Limited’s return on equity (ROE) is -0.57 and return on invested capital (ROIC) is -11.62%.
Return on Equity (ROE)-0.57
Return on Assets (ROA)-0.24
Return on Invested Capital (ROIC)-11.62%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee687.39K
Profits Per Employee-225.02K
Employee Count290
Asset Turnover0.80
Inventory Turnover8.90
Valuation Ratios
The current PE Ratio of Raily Aesthetic Medicine International Holdings Limited is -0.16. Raily Aesthetic Medicine International Holdings Limited’s PEG ratio is 7.47.
PE Ratio-0.16
PS Ratio0.00
PB Ratio7.58
Price to Fair Value0.09
Price to FCF-59.58
Price to Operating Cash Flow-553.34
PEG Ratio7.47
Income Statement
In the last 12 months, Raily Aesthetic Medicine International Holdings Limited had revenue of 199.34M and earned -59.21M in profits. Earnings per share was 0.00.
Revenue199.34M
Gross Profit71.41M
Operating Income-18.67M
Pretax Income-65.26M
Net Income-59.21M
EBITDA-34.29M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 5.04M and capital expenditures -9.00M, giving a free cash flow of -4.99M billion.
Operating Cash Flow5.04M
Free Cash Flow-4.99M
Free Cash Flow per Share>-0.01
Dividends & Yields
Raily Aesthetic Medicine International Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.71
52-Week Price Change8.33%
50-Day Moving Average0.12
200-Day Moving Average0.12
Relative Strength Index (RSI)65.57
Average Volume (3m)146.10K
Important Dates
Raily Aesthetic Medicine International Holdings Limited upcoming earnings date is Aug 22, 2025, TBA (Not Confirmed).
Last Earnings DateMar 28, 2025
Next Earnings DateAug 22, 2025
Ex-Dividend Date―
Financial Position
Raily Aesthetic Medicine International Holdings Limited as a current ratio of 0.73, with Debt / Equity ratio of 29.03%
Current Ratio0.73
Quick Ratio0.62
Debt to Market Cap2.15
Net Debt to EBITDA-0.80
Interest Coverage Ratio-6.65
Taxes
In the past 12 months, Raily Aesthetic Medicine International Holdings Limited has paid -1.99M in taxes.
Income Tax-1.99M
Effective Tax Rate0.03
Enterprise Valuation
Raily Aesthetic Medicine International Holdings Limited EV to EBITDA ratio is -1.08, with an EV/FCF ratio of -0.96.
EV to Sales0.19
EV to EBITDA-1.08
EV to Free Cash Flow-0.96
EV to Operating Cash Flow6.19
Balance Sheet
Raily Aesthetic Medicine International Holdings Limited has HK$39.79M in cash and marketable securities with ¥51.78M in debt, giving a net cash position of HK$11.99M billion.
Cash & Marketable SecuritiesHK$39.79M
Total Debt¥51.78M
Net CashHK$11.99M
Net Cash Per ShareHK$0.02
Tangible Book Value Per ShareHK$0.47
Margins
Gross margin is 40.59%, with operating margin of -9.37%, and net profit margin of -29.70%.
Gross Margin40.59%
Operating Margin-9.37%
Pretax Margin-32.74%
Net Profit Margin-29.70%
EBITDA Margin-17.20%
EBIT Margin-31.33%
Analyst Forecast
The average price target for Raily Aesthetic Medicine International Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3.14%
EPS Growth Forecast-57.92%